Related Experiment Video
Updated: May 30, 2026

Murine Bilateral Renal Lymphadenectomy
Published on: December 30, 2025
[Damage in cuban patients with systemic lupus erythematosus. Relation with disease features]
Miguel Estévez Del Toro1, Araceli Chico Capote, Rafael Hechavarría
1Servicio de Reumatología, Hospital Hermanos Ameijeiras, Ciudad de La Habana, Cuba.
Insights
Nearly half of Cuban patients with systemic lupus erythematosus (SLE) experienced organ damage. High-dose prednisone use and leukopenia were key predictors of damage in SLE patients.
Area of Science:
- Rheumatology
- Clinical Immunology
- Internal Medicine
Context:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with potential for significant organ damage.
- Understanding damage predictors in SLE is crucial for timely intervention and improved patient outcomes.
- Cuban SLE patient data offers unique insights into disease manifestations and progression.
Purpose:
- To identify the prevalence of organ damage in a cohort of Cuban patients with SLE.
- To determine the factors associated with the development of damage in these patients.
- To inform clinical practice and future research directions for SLE management.
Summary:
- A retrospective cohort study of 80 Cuban SLE patients revealed that 48.8% had organ damage.
- The musculoskeletal system was most frequently affected, followed by neuropsychiatric, skin, pulmonary, and ocular domains.
- Multivariate analysis identified high-dose prednisone use (>30 mg/day for >4 weeks), leukopenia, and disease duration as significant predictors of damage.
Impact:
- This study highlights the substantial burden of damage in SLE patients.
- Findings underscore the importance of monitoring for damage, particularly in patients with identified risk factors.
- Results can guide therapeutic strategies to mitigate damage accrual in SLE.
Objective:
To determine damage presence and predictors factors for its appearance in a cohort of cuban patients with systemic lupus erythematosus (SLE).
Patients And Methods:
A retrospective cohort study included 80 patients presenting with SLE seen in Rheumatology Service of "Hermanos Ameijeiras" Clinical Surgical Hospital in Havana City, Cuba. Damage was assessed using The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (ACR) Damage Index (SLIC/ACR), a tool approved for damage measurement. Damage presence was related to initial disease features to diagnose this condition, to sociodemographic elements, to treatments used, and to the disease course time. Statistical analysis had two variants: the univariate and multivariate type using Chi2 and statistical significance was established in p<0, 05.
Results:
We found that 39 patients (48,8%) had some degree of damage. More involved domains were the musculoskeletal (18,8%), neuropsychiatric, and skin, 16,3%, pulmonary and ocular, present in 15% of cases. In the multivariate analysis, damage was associated with the use of higher than 30 mg/day Prednisone doses for more of 4 weeks (OR=54,68, CI 95%=3,56-97,45, p=0.001), presence of leukopenia (RO=18,73, CI 95%=2,74-62,23m p=0,004), and time course of disease (OR=1,02, CI 95%=1,00 2-1,09, p=0.006).
Conclusions:
Damage was practically present in half of the study patients, the most involved domain was the musculoskeletal, and use of higher than 30mg prednisone doses were the factor most associated with the presence of damage.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Hypersensitivity Reactions: Immune-Complex Reactions
Hypersensitivity Reactions: Cytolytic Reactions
